News 30 Apr 2025 Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz
Scientific articles 29 Apr 2025 Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study The Lancet Global Health
Scientific articles 29 Apr 2025 Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study The Lancet Global Health
News 25 Apr 2025 Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
In the media 23 Apr 2025 Race against time: New treatment for deadly HIV complication enters trials Daily Nation
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Scientific articles 21 Apr 2025 A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2025 Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network The Lancet Child & Adolescent Health
In the media 17 Apr 2025 New treatment for deadly HIV-linked meningitis enters phase II trial The Standard
In the media 17 Apr 2025 Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai RTS
In the media 16 Apr 2025 Accord historique à l’OMS sur la préparation et la lutte contre les futures pandémies AFP
In the media 16 Apr 2025 Luz verde para un “histórico” tratado mundial contra pandemias impulsado por la OMS El País
Press releases 30 Oct 2019 Not-for-profit research and development can address deadly market failure for neglected patients, paper shows
Press releases 18 Oct 2019 The French development agency AFD renews its support for the Drugs for Neglected Diseases initiative (DNDi) in researching and developing treatments for neglected tropical diseases
Press releases 26 Sep 2019 Lack of awareness of Chagas disease in the US leading to unnecessary deaths in vulnerable immigrant communities
Press releases 15 Sep 2019 La cuvée 2018 de la ‘Vigne des Nations’ de la République et canton de Genève dédiée à DNDi en reconnaissance de son travail auprès des patients les plus négligés
Press releases 22 Jul 2019 Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows
Press releases 17 Jul 2019 Nationwide hepatitis C screening campaign initiated by the Malaysian Ministry of Health
Press releases 20 Jun 2019 Chagas Access Programme achieves an increase of 1300% in the number of people screened
Press releases 24 May 2019 Following 110 years of neglect, an official day for Chagas disease is declared
Press releases 16 Apr 2019 DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases
Press releases 14 Mar 2019 Study shows dramatically shorter treatment for Chagas disease could be just as effective, and significantly safer
Press releases 5 Feb 2019 Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Press releases 30 Jan 2019 Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
Press releases 29 Jan 2019 MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases
Press releases 23 Jan 2019 Drugs for Neglected Diseases initiative and The BMJ launch a special collection on neglected diseases and innovation in South Asia
